Search

Sahar Javanmard

Examiner (ID: 6799, Phone: (571)270-3280 , Office: P/1627 )

Most Active Art Unit
1627
Art Unit(s)
1617, 1622, 1627
Total Applications
1199
Issued Applications
643
Pending Applications
130
Abandoned Applications
470

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 14273341 [patent_doc_number] => 20190133955 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-09 [patent_title] => ORALLY DISINTEGRATING DOSAGE FORM FOR ADMINISTRATION OF AVANAFIL, AND ASSOCIATED METHODS OF MANUFACTURE AND USE [patent_app_type] => utility [patent_app_number] => 16/014093 [patent_app_country] => US [patent_app_date] => 2018-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14235 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16014093 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/014093
ORALLY DISINTEGRATING DOSAGE FORM FOR ADMINISTRATION OF AVANAFIL, AND ASSOCIATED METHODS OF MANUFACTURE AND USE Jun 20, 2018 Abandoned
Array ( [id] => 14338579 [patent_doc_number] => 20190151262 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-23 [patent_title] => USE OF N-ACETYLCYSTEINE AMIDE FOR DECREASING INTRACRANIAL PRESSURE [patent_app_type] => utility [patent_app_number] => 16/011225 [patent_app_country] => US [patent_app_date] => 2018-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5257 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16011225 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/011225
USE OF N-ACETYLCYSTEINE AMIDE FOR DECREASING INTRACRANIAL PRESSURE Jun 17, 2018 Abandoned
Array ( [id] => 15264423 [patent_doc_number] => 20190380945 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-12-19 [patent_title] => Method for Degrading Bilirubin in Skin [patent_app_type] => utility [patent_app_number] => 16/010944 [patent_app_country] => US [patent_app_date] => 2018-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6369 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16010944 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/010944
Method for degrading bilirubin in skin Jun 17, 2018 Issued
Array ( [id] => 13618519 [patent_doc_number] => 20180360811 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-20 [patent_title] => Methods and Compositions to Inhibit Symptoms Associated with Viral Upper Respiratory Tract Infections [patent_app_type] => utility [patent_app_number] => 16/009751 [patent_app_country] => US [patent_app_date] => 2018-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5533 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16009751 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/009751
Methods and Compositions to Inhibit Symptoms Associated with Viral Upper Respiratory Tract Infections Jun 14, 2018 Abandoned
Array ( [id] => 16572118 [patent_doc_number] => 10894029 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-01-19 [patent_title] => Neuroprotective compositions and their use [patent_app_type] => utility [patent_app_number] => 16/009490 [patent_app_country] => US [patent_app_date] => 2018-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 21 [patent_no_of_words] => 4799 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16009490 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/009490
Neuroprotective compositions and their use Jun 14, 2018 Issued
Array ( [id] => 13444033 [patent_doc_number] => 20180273559 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-09-27 [patent_title] => GOLD COMPLEXES OF ALKYLATED PHOSPHINES [patent_app_type] => utility [patent_app_number] => 15/993163 [patent_app_country] => US [patent_app_date] => 2018-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17182 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15993163 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/993163
Gold complexes of alkylated phosphines May 29, 2018 Issued
Array ( [id] => 17451776 [patent_doc_number] => 11266611 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-03-08 [patent_title] => More potent and less toxic formulations of epinephrine and methods of medical use [patent_app_type] => utility [patent_app_number] => 15/991501 [patent_app_country] => US [patent_app_date] => 2018-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8216 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 222 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15991501 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/991501
More potent and less toxic formulations of epinephrine and methods of medical use May 28, 2018 Issued
Array ( [id] => 13444031 [patent_doc_number] => 20180273558 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-09-27 [patent_title] => COMPOSITION CONTAINING A GOLD (I) COMPLEX AND CANCER CELLS [patent_app_type] => utility [patent_app_number] => 15/990289 [patent_app_country] => US [patent_app_date] => 2018-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17159 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15990289 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/990289
Composition containing a gold (I) complex and cancer cells May 24, 2018 Issued
Array ( [id] => 13425253 [patent_doc_number] => 20180264169 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-09-20 [patent_title] => COMPOSITIONS COMPRISING AT LEAST ONE POLYOL AND AT LEAST ONE ANESTHETIC [patent_app_type] => utility [patent_app_number] => 15/986371 [patent_app_country] => US [patent_app_date] => 2018-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22608 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15986371 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/986371
COMPOSITIONS COMPRISING AT LEAST ONE POLYOL AND AT LEAST ONE ANESTHETIC May 21, 2018 Abandoned
Array ( [id] => 13220503 [patent_doc_number] => 10124011 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-11-13 [patent_title] => Methods of treating erectile dysfunction [patent_app_type] => utility [patent_app_number] => 15/982713 [patent_app_country] => US [patent_app_date] => 2018-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 6812 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15982713 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/982713
Methods of treating erectile dysfunction May 16, 2018 Issued
Array ( [id] => 13424853 [patent_doc_number] => 20180263969 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-09-20 [patent_title] => COMPOSITIONS AND METHODS FOR TREATING BACTERIAL INFECTIONS [patent_app_type] => utility [patent_app_number] => 15/982974 [patent_app_country] => US [patent_app_date] => 2018-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9491 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15982974 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/982974
COMPOSITIONS AND METHODS FOR TREATING BACTERIAL INFECTIONS May 16, 2018 Abandoned
Array ( [id] => 14818315 [patent_doc_number] => 10406143 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-09-10 [patent_title] => Methods for treatment of fabry disease [patent_app_type] => utility [patent_app_number] => 15/974222 [patent_app_country] => US [patent_app_date] => 2018-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12640 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15974222 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/974222
Methods for treatment of fabry disease May 7, 2018 Issued
Array ( [id] => 13548667 [patent_doc_number] => 20180325881 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-11-15 [patent_title] => Methods for Treatment of Fabry Disease [patent_app_type] => utility [patent_app_number] => 15/974217 [patent_app_country] => US [patent_app_date] => 2018-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12616 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15974217 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/974217
Methods for treatment of Fabry disease May 7, 2018 Issued
Array ( [id] => 13602599 [patent_doc_number] => 20180352848 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-13 [patent_title] => SMOKABLE CANNABIS-BASED PRODUCT WITH REDUCED PSYCHOACTIVE EFFECTS [patent_app_type] => utility [patent_app_number] => 15/968053 [patent_app_country] => US [patent_app_date] => 2018-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12519 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 179 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15968053 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/968053
SMOKABLE CANNABIS-BASED PRODUCT WITH REDUCED PSYCHOACTIVE EFFECTS Apr 30, 2018 Abandoned
Array ( [id] => 16215027 [patent_doc_number] => 10730825 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-08-04 [patent_title] => Methods for the treatment of diabetic retinopathy and other ophthalmic diseases [patent_app_type] => utility [patent_app_number] => 15/967080 [patent_app_country] => US [patent_app_date] => 2018-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 31 [patent_no_of_words] => 37326 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15967080 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/967080
Methods for the treatment of diabetic retinopathy and other ophthalmic diseases Apr 29, 2018 Issued
Array ( [id] => 16518620 [patent_doc_number] => 10869822 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-12-22 [patent_title] => Compositions for treatment of dermatological diseases and conditions and methods of use thereof [patent_app_type] => utility [patent_app_number] => 15/962436 [patent_app_country] => US [patent_app_date] => 2018-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 19 [patent_no_of_words] => 11916 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15962436 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/962436
Compositions for treatment of dermatological diseases and conditions and methods of use thereof Apr 24, 2018 Issued
Array ( [id] => 17525648 [patent_doc_number] => 11298314 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-04-12 [patent_title] => Injectable composition for localized fat reduction without pain, edema, and side effects, and method for preparing same [patent_app_type] => utility [patent_app_number] => 16/311960 [patent_app_country] => US [patent_app_date] => 2018-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 77 [patent_no_of_words] => 38320 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16311960 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/311960
Injectable composition for localized fat reduction without pain, edema, and side effects, and method for preparing same Apr 19, 2018 Issued
Array ( [id] => 13457597 [patent_doc_number] => 20180280341 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-10-04 [patent_title] => MAST CELL STABILIZERS TREATMENT FOR SYSTEMIC DISORDERS [patent_app_type] => utility [patent_app_number] => 15/957724 [patent_app_country] => US [patent_app_date] => 2018-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31862 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15957724 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/957724
MAST CELL STABILIZERS TREATMENT FOR SYSTEMIC DISORDERS Apr 18, 2018 Abandoned
Array ( [id] => 13586271 [patent_doc_number] => 20180344684 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-06 [patent_title] => CANNABIS-BASED THERAPEUTIC PRODUCT FOR TREATMENT OF SLEEP DISORDERS [patent_app_type] => utility [patent_app_number] => 15/954536 [patent_app_country] => US [patent_app_date] => 2018-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10699 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 152 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15954536 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/954536
CANNABIS-BASED THERAPEUTIC PRODUCT FOR TREATMENT OF SLEEP DISORDERS Apr 15, 2018 Abandoned
Array ( [id] => 13942287 [patent_doc_number] => 10206888 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-02-19 [patent_title] => Cannabis-based therapeutic product for treatment of chronic pain [patent_app_type] => utility [patent_app_number] => 15/952875 [patent_app_country] => US [patent_app_date] => 2018-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10637 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 154 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15952875 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/952875
Cannabis-based therapeutic product for treatment of chronic pain Apr 12, 2018 Issued
Menu